Opinion
Video
Author(s):
Experts briefly mention other ongoing phase 3 studies investigating TAR-200 for the treatment of non–muscle-invasive bladder cancer (NMIBC).
Video content above is prompted by the following:
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.